News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

aTyr Pharma, A US-Hong Kong Biotech, Announces $46 Million Private Placement



8/29/2017 11:01:29 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
aTyr Pharma, a San Diego-Hong Kong biotherapeutics company, announced a $45.8 million private placement. The company will use the capital to advance its portfolio, which aims to treat rare immune-mediated diseases and cancer. In several Phase Ib/II trials, the company's lead drug, Resolaris, showed efficacy. aTyr says the drug "resets" the immune system without making patients susceptible to disease. The company's majority owned subsidiary, Pangu BioPharma, operates a research laboratory at the Hong Kong University of Science and Technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES